Access to health care
As a comprehensive pharmaceuticalenterprise which integrates medical manufacture,health care,circulation and retail,We take health for all as our unswerving objective, and provide new solutionsto the people's health with continually innovative products and medical serviceprograms.
By the end of 2018,GYBYS had built 78R&D institutions(9 types) such as national R&D institutions andnational enterprise technology centers
In 2018,we received 2 drug productionapprovals and 6 clinical approvals
We applied f or 125 patents，and we were ized with 52 patents
2017,Baiyunshan General Factory joinedhands with iSEEK PH Hope Center to start the love aid themed on "JinGeNew Life Program for Patients with Blue Lips",benefits to 1,715 patients withpulmonary hypertension.
In 2018 ,we invested RMB 19,000 intotal,and provided training for over 400 primary physicians.
n OurApproach to Access to healthcare
We takes "caring for life and pursuing excellence" as the mission,and gives full play to its own resources superiorityin healthcare industry. Based on continuous research and development of innovativedrugs,the Group adopts a fair and reasonable pricing policy,actively helps withthe development of primary care,carries out medical public benefitactivities,and passes health knowledge and pharmaceutical products to patientsin need.